Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 25, 2026

Hemagen Diagnostics Company Description

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide.

The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins.

Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases.

It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines.

In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas.

Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.

Hemagen Diagnostics, Inc.
Country United States
Founded 1985
Industry Biotechnology
Sector Healthcare
Employees 15
CEO William Hales

Contact Details

Address:
9033 Red Branch Road
Columbia, Maryland 21045
United States
Phone 443-367-5500
Website hemagen.com

Stock Details

Ticker Symbol HMGN
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year October - September
Reporting Currency USD
ISIN Number US4235011057
SIC Code 2835

Key Executives

Name Position
William P. Hales Executive Chairman, Chief Executive Officer and President
M. Robert Campbell Chief Financial Officer and Chief Operating Officer